Latest News
Radiopharm Theranostics
News & Updates
Stay informed with the latest news, press releases, clinical trial progress, and company announcements from Radiopharm Theranostics as we advance radiopharmaceutical innovation.
Categories
Recent News
Cancer Research Milestones and 2025 Roadmap
Cancer Research Milestones and 2025 Roadmap Radiopharm Theranostics (ASX:RAD) is dedicated to developing innovative radiopharmaceutical products for both diagnostic and therapeutic applications, addressing high unmet medical needs. In 2024, the company made significant strides in its cancer research. In this
Tags
Archives
Archives
RSS
- Annual Report Year Ended 30 June 2025
- RAD KOL Webinar on Pivalate
- NDR and Webinar Takeaways Along with Upcoming Clinical Data
- RAD Presentation August 2025
- Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
- FQ4 Update: Modest Slippage in Some Readouts
